News & Perspective

Nov 17, 2017

Nov 17, 2017

ASP Scan (Weekly) for Nov 17, 2017

Primary care stewardship
No-touch superbug disinfection
Surgical antimicrobial prescribing
Ceftriaxone-resistant gonorrhea
E coli ST131
Single-room ICU design
ECDC CRE guidance
European research funding
Optimal MDR-TB treatment
Real-time resistance tracker
Salmonella in calves
Drug-resistant malaria controversy
US AMR progress
Antimicrobial use in Northern Ireland
Resistance in space

Jun 25, 2013

Jun 25, 2013

HHS awards grant for antibiotic to fight melioidosis, glanders

HHS awarded $16.8 million to a Swiss company for a new antibiotic for melioidosis and glanders.

Nov 24, 2009

Nov 24, 2009

Novartis unveils US cell-based flu vaccine plant

(CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore production and marketing of cell-based vaccines remains a few years away.

Apr 30, 2009

Apr 30, 2009

SWINE FLU BREAKING NEWS: Case counts, antiviral distribution, Mexican situation, Biden's clarification, new countries affected, viral name change, White House health scare

 

The World Health Organization's (WHO's) global count of confirmed swine flu cases stands at 257 cases in 11 countries today. The United States has 109 cases and 1 death; Mexico has 97 cases and 7 deaths. [WHO update 6]

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Aug 16, 2007

Aug 16, 2007

Glaxo sells more H5N1 vaccine to US, launches trial

(CIDRAP News) – The British pharmaceutical company GlaxoSmithKline (GSK) recently announced another major order of prepandemic H5N1 influenza vaccine from the US Department of Health and Human Services (HHS), along with plans to launch a North American clinical trial of the vaccine.

Apr 26, 2007

Apr 26, 2007

Roche cuts Tamiflu production as demand cools

(CIDRAP News) – The Swiss pharmaceutical company Roche announced today it is scaling back production of oseltamivir (Tamiflu) because of waning demand, and simultaneously questioned whether countries stockpiling the drug are buying enough to protect their citizens in the event of an influenza pandemic.

Nov 08, 2005

Nov 08, 2005

US calls for expert panel to plan pandemic response

(CIDRAP News) – The United States proposed today that a small group of experts be appointed immediately to plan a fast response in case an influenza pandemic erupts, as an international conference on avian and pandemic flu continued in Geneva.

Nov 12, 2004

Nov 12, 2004

WHO says nations must fund work on pandemic flu vaccines

(CIDRAP News) – The World Health Organization's top influenza expert warned at the end of a 2-day international meeting today that governments need to fund the development of vaccines to combat a feared flu pandemic that could kill millions of people, according to news services.

Pages

Sort Results

 

Narrow results

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»